Chapter 6 Index cardiotoxicity

Index cardiotoxicity identifier is [ic]

There is a little ambiguity here: index cardiotoxicity refers both to the date of cardiotoxicity diagnosis AND date of hospital admission (if any) for this cardiotoxicity.

6.1 Abbreviations

Abbreviation(s) Feature
Clinical work-up
sy Symptoms
ctx Cardiotoxicity (used for the description of timings between a ctx symptoms ctx sy and index date, and grading).
pe Physical examination features
irae Features of non-cardiac immune related adverse events at the index date
hyper, hypo, aiha, attp, hus, aa, id, bd, scar For iraes subclasses, small adds to refer to the correct subclass (hyperthyroidism, hypothyroidism, auto-immune hemolytic anemia, acquired thrombotic thrombocytopenic purpura, hemolytic and uremic syndrome, aplastic anemia, inflammatory dermatitis, bullous dermatosis, severe cutaneous adverse reaction)
Exams
bx Biopsy features (muscular, cardiac, other)
lhc Left Heart Catheterization

Treatment section

tx

immsup Immunosuppressant
4-character abbreviation for immunosuppressants

ivig

plas

tacy

myco

othr

athg

infl

abab

mtor

cycl

azat

ritu

Intravenous Immunoglobulin

Plasmapheresis (PLEX)

Tacrolimus or cyclosporin

Mycophenolate mofetil

Other immunosuppressant

ATG / thymoglobulin

Infliximab or other anti-TNFalpha

Abatacept or belatacept

mTOR inhibitors (temsirolimus, everolimus, sirolimus)

Cyclophosphamide

Azathioprine

Rituximab

ms Mechanical support
aa Anti-arrhythmic drugs or devices

6.2 Biological features

Most normal values of biological parameters are different from one lab to another. Also, users may report bio vars according to different scales.

Examples: troponin upper limit of normal may range from ~ 0.01 to ~ 50. Complete blood count can be reported in G/L or 10^-3/µL (even if the var field asked for reporting with one of them).

It is advised to express biological parameters according to their normal value range if known, or to contrast them into ratios that get rid of the unit (example: neutrophil to lymphocyte ratio)

6.3 Diagnosis staging according to Bonaca’s

Bonaca’s criteria were summarised in ic_ctx1_certainty_adjudication.